This document discusses leukemia and thalassemia. It describes:
1. The two main types of acute leukemia - acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). ALL is more common in children while AML is more common in adults.
2. The causes of acute leukemia which include genetic mutations, exposure to radiation, chemicals and viruses. Certain genetic disorders also increase risk.
3. The signs and symptoms of acute leukemia which include fatigue, fever, infections, bleeding and organ enlargement due to proliferation of abnormal white blood cells.
4. The treatments for acute leukemia involve chemotherapy to eliminate leukemia cells and induce remission as well as managing infections with antibiotics
This document discusses leukemia and thalassemia. It describes:
1. The two main types of acute leukemia - acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). ALL is more common in children while AML is more common in adults.
2. The causes of acute leukemia which include genetic mutations, exposure to radiation, chemicals and viruses. Certain genetic disorders also increase risk.
3. The signs and symptoms of acute leukemia which include fatigue, fever, infections, bleeding and organ enlargement due to proliferation of abnormal white blood cells.
4. The treatments for acute leukemia involve chemotherapy to eliminate leukemia cells and induce remission as well as managing infections with antibiotics
This document discusses leukemia and thalassemia. It describes:
1. The two main types of acute leukemia - acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). ALL is more common in children while AML is more common in adults.
2. The causes of acute leukemia which include genetic mutations, exposure to radiation, chemicals and viruses. Certain genetic disorders also increase risk.
3. The signs and symptoms of acute leukemia which include fatigue, fever, infections, bleeding and organ enlargement due to proliferation of abnormal white blood cells.
4. The treatments for acute leukemia involve chemotherapy to eliminate leukemia cells and induce remission as well as managing infections with antibiotics
This document discusses leukemia and thalassemia. It describes:
1. The two main types of acute leukemia - acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). ALL is more common in children while AML is more common in adults.
2. The causes of acute leukemia which include genetic mutations, exposure to radiation, chemicals and viruses. Certain genetic disorders also increase risk.
3. The signs and symptoms of acute leukemia which include fatigue, fever, infections, bleeding and organ enlargement due to proliferation of abnormal white blood cells.
4. The treatments for acute leukemia involve chemotherapy to eliminate leukemia cells and induce remission as well as managing infections with antibiotics
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 39
LEUKEMIA DAN THALASEMIA
DWI NOVITASARI, S.Kep., Ns., M.Sc
Development of blood cells from the bone marrow Division of stem cell into blood cells Acute leukemia • Acute leukemia is one form of leukemia. • Leukemia refers to a group of malignant disorders • characterized by abnormal proliferation and maturation of lymphocytes and nonlymphocytic cells, • leading to the suppression of normal cells Type of Acute leukemia
• Treatment leads to remission in 81% of children, who survive an average of 5 years, • in 65% of adults, who survive an average of 2 years. • Children between ages 2 and 8 who receive intensive therapy have the best survival rate 2. Acute Myeloid Leukemia (AML)
• is one of the most common leukemias in
adults. • Average survival time is only 1 year after diagnosis even with aggressive treatment. • Remissions lasting 2 to 10 months occur in 50% of children Cause • The exact cause of acute leukemia isn’t known • 40% to 50% of patients have mutations in their chromosomes. • Individuals with certain chromosomal disorders have a higher risk. • Down syndrome, trisomy 13, and other heredity disorders have a higher incidence of leukemia. risk factors • certain viruses, such as human T-cell lymphotrophic virus • cigarette smoking • exposure to certain chemicals (such as benzene, which is present in cigarette smoke and gasoline) • exposure to large doses of ionizing radiation or drugs that depress the bone marrow Pathophysiology • Immature hematopoietic cells undergo an abnormal transformation, giving rise to leukemic cells. • Leukemic cells multiply and accumulate, crowding out other types of cells. • Crowding prevents production of normal red blood cells and white blood cells (WBCs) and platelets, leading to pancytopenia Pathophysiology
• Pancytopenia is reduction in the number of all
cellular elements of the blood. Clinical Findings • Infection related to myelosuppression from treatment, direct invasion of the bone marrow, development of fistulas, or immunosuppression from hormonal release in response to chronic stress Clinical Findings • Bleeding due to thrombocytopenia from bone marrow suppression. Even when the platelet count is normal, platelet function may be impaired in hematologic cancers. • Anemia due to cancer of the blood forming cells, WBCs, or RBCs Clinical Findings • Malaise and lethargy related to anemia, as there are fewer functional cells to maintain metabolism • Fever and night sweats resulting from bone marrow invasion and cellular proliferation within bone marrow Clinical Findings
• pain due to infiltration of bone marrow
• paleness and weakness due to anemia • weight loss due to generalized wasting of fat and protein, and decreased appetite Diagnostic acute leukemia Treatment acute leukemia
• Systemic chemotherapy to eradicate leukemic
cells and induce remission • Antibiotic, antifungal, and antiviral drugs • Colony-stimulating factors such as filgrastim (Neupogen) to spur the growth of granulocytes, RBCs, and platelets • Transfusions of platelets to prevent bleeding and RBCs to prevent anemia Chronic leukemia
• is the most benign and slowest progress
inform of leukemia. • This type of chronic leukemia occurs most commonly in elderly people, and more than one half of the cases are male Chronic leukemia
• The prognosis is poor if anemia,
thrombocytopenia, neutropenia, bulky lymphadenopathy, or severe lymphocytosis develops. • is the most common cause of death, usually 4 to 5 years after diagnosis. Cause
• It causes a proliferation and accumulation of relatively mature looking but immunologically inefficient lymphocytes. • After these cells infiltrate, clinical signs appear Clinical Findings
• Fever resulting from bone marrow invasion
and cellular proliferation within bone marrow • Bleeding tendencies secondary to thrombocytopenia • Frequent infections related to deficient humoral immunity Clinical Findings
• Fatigue related to anemia
• Enlargement of lymph nodes and hepatomegaly from infiltration by leukemic cells • Splenomegaly secondary to increased numbers of lysed red blood cells being filtered Diagnostic chonic lymphocitic leukemia Treatment • Systemic chemotherapy, using the alkylating drugs chlorambucil (Leukeran) or cyclophosphamide (Cytoxan), with presence of autoimmune hemolytic anemia or thrombocytopenia
• Prednisone for refractory disease
Treatment
• Local radiation to reduce organ size and help
to relieve symptoms when obstruction or organ impairment or enlargement occurs • Radiation therapy for enlarged lymph nodes, painful bony lesions, or massive splenomegaly • Allopurinol (Zyloprim) to prevent hyperuricemia THALASSEMIA Karakteristik Thalassemia This illustration shows how white blood cells (agranulocytes and granulocytes) proliferate in the bloodstream in leukemia, overwhelming red blood cells (RBCs) and platelets. Sign and symptoms Sign and symptoms
Senate Hearing, 113TH Congress - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations For Fiscal Year 2015